Entry requirements

Normally a 2:1 honours degree or equivalent in a Biological Sciences subject, Bioprocessing or Biochemical Engineering, but relevant experience may be taken into account.

In addition, applicants will need to demonstrate leadership potential, which might be evidenced from academic, sporting, volunteering or other professional experience.

Months of entry


Course content

Accelerated training for Biopharmaceutical Industry

This unique professional training programme has been designed and developed in collaboration with the multinational Contract Research Organisation, Covance.

The course is 20 months long, covering campus-based taught modules in the first six months, followed by a 12-month guaranteed paid placement in industry where you can expect to earn around £20,000.

During your training you’ll gain an integrated understanding of the full biological drug development pathway and the regulatory framework. The focus will be on large molecule drugs: monoclonal antibodies like Herceptin, bio-similars and antibody-drug conjugates; gene therapies and the technologies that underpin the discovery and development pathway.

You’ll be taught by leading industrialists and internationally renowned academics working at the forefront of their fields in the areas of science that support drug development. The curriculum is delivered primarily via project work in teams, and is assessed with outputs that are commonplace in industry, including presentations and reports to clients, regulators, investors/sponsors etc.

To prepare you for work in industry, you’ll also have access to cutting-edge practical technologies and gain hands-on practical training in protein purification, characterisation, formulation and assessment of binding function. In addition, you’ll use cell-based assays to look at drug potency, all performed in a strict regulated environment.

This course will help give you the experience and skills to become highly employable. Many pharmaceutical companies are expanding their biopharmaceutical capability, which is creating demand and opportunities for talented, well-trained people. At the same time, these companies report difficulties in recruiting employees with relevant skill sets and those with broad industrial experience are greatly sought after.

To address this skills gap, the University of Leeds and Covance have formed this partnership to train the next generation of talented scientists for the biopharmaceutical industry.

This course will provide you with an understanding of biological drug development focusing on each of the major steps of the process:

  • discovery
  • manufacturing
  • pre-clinical testing
  • clinical trials
  • market access and
  • the regulatory and legal aspects framework that ensure safe practice and the development of safe and effective medicines.

Fees and funding

MedImmune are offering one full fee scholarship to students that have been offered a place on this Masters.

To apply for this scholarship offer holders need to send their most up to date CV to fbspgt@leeds.ac.ukwhich will then be forwarded to Medimmune for consideration. The selected student will then undertake their 12-month placement with MedImmune in Cambridge (unpaid).

Application deadline - 17th June 2018

If you have the talent and drive, we want you to be able to study with us, whatever your financial circumstances. There may be help for students in the form of loans and non-repayable grants from the University and from the government. Find out more at Masters funding overview.

We award a generous range of scholarships and consider all eligible applicants who demonstrate outstanding academic achievement and excellent personal and professional skills.

Visit our FBS fees and scholarships page to find out more about the range of scholarships we have to offer.

Qualification and course duration


full time
20 months

Course contact details

Faculty of Biological Sciences Postgraduate Admissions
(0) 113 343 1418